Hilberg O, Hoffmann-Vold AM, Smith V, et al. Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries. ERJ Open Res 2022; 8: 00597-2021.
Zanella D, Guiot J, Stefanuto PH, et al. Breathomics to diagnose systemic sclerosis using thermal desorption and comprehensive two-dimensional gas chromatography high-resolution time-of-flight mass spectrometry. Anal Bioanal Chem 2021; 413: 3813–3822.
van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2013; 65: 2737–2747.
Raghu G, Montesi SB, Silver RM, et al. Treatment of systemic sclerosis–associated interstitial lung disease: evidence-based recommendations. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med 2024; 209: 137–152.
Schleich FN, Zanella D, Stefanuto PH, et al. Exhaled volatile organic compounds are able to discriminate between neutrophilic and eosinophilic asthma. Am J Respir Crit Care Med 2019; 200: 444–453.
Xia J, Psychogios N, Young N, et al. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res 2009; 37: Suppl. 2, W652–W660.
Distler O, Assassi S, Cottin V, et al. Predictors of progression in systemic sclerosis patients with interstitial lung disease. Eur Respir J 2020; 55: 1902026.
Zanella D, Henket M, Schleich F, et al. Comparison of the effect of chemically and biologically induced inflammation on the volatile metabolite production of lung epithelial cells by GC×GC-TOFMS. Analyst 2020; 145: 5148–5157.
Hakim M, Broza YY, Barash O, et al. Volatile organic compounds of lung cancer and possible biochemical pathways. Chem Rev 2012; 112: 5949–5966.
Gaude E, Nakhleh MK, Patassini S, et al. Targeted breath analysis: exogenous volatile organic compounds (EVOC) as metabolic pathway-specific probes. J Breath Res 2019; 13: 32001.
Fernández Del Río R, O’Hara ME, Holt A, et al. Volatile biomarkers in breath associated with liver cirrhosis-comparisons of pre-and post-liver transplant breath samples. EBioMedicine 2015; 2: 1243–1250.
